We have compared in vitro binding of adriamycin ( ADR ) and amsacrine ( AMSA )
研究了阿霉素 ( ADR ) 和安吖啶 ( AMSA ) 與小牛胸腺DNA結合 成復合物的藥理特性.ADR與DNA的 結合強度約相當AMSA的 100倍.
互聯網
Adriamycin can selectively kill perikaryon by way of retrograde axoplasmic transport.
阿霉素(多柔比星)可以通過逆向軸漿運輸選擇性殺死神經元胞體.
互聯網
Methods A 549 cells were treated with adriamycin ( ADM ) .
方法采用阿霉素誘導 A549 使其耐藥.
互聯網
Objective : To study the effect of glucocorticoid on urinary protein excretion in adriamycin nephrosis ( AN ) rats.
目的: 了解腎上腺糖皮質激素對阿霉素 腎病 大鼠尿蛋白排泄的影響.
互聯網
Objective To study the preparation technology of lung targeting adriamycin gelatin microspheres ( ADM - GMS ) and their characteristics.
目的制備肺靶向阿霉素明膠微球 ( ADM-GMS ) 并考察其特性.
互聯網
Objective To explore the ideal method to treat tissue injury caused by Adriamycin effusion.
目的探討阿霉素外滲致組織損傷的理想治療方法.
互聯網
Objective To observe the effect of adriamycin to suborbital nerve and trigeminal ganglion in the rabbits.
目的觀察阿霉素對兔眶下神經及三叉神經節的作用.
互聯網
Recent studies have demonstrated that EPO has protective effects on myocardial infarction, ischemia - reperfusion and adriamycin - myocardial damage.
最近的研究提示,EPO對心肌梗死 、 缺血再灌注損傷及阿霉 素心 肌損害等具有保護作用.
互聯網
Objective : To evaluate the effective and safety of double - guided method adriamycin therapy for primary trigeminal neuralgia.
目的: 評價我科采用的新方法—阿霉素雙引導法治療原發性三叉神經痛的安全性與有效性.
互聯網
To observe the effects of Shenluotong on the cell phenotype conversion in rats with adriamycin - induced nephrothy.
目的腎絡通對阿霉素誘導的腎病大鼠細胞表型轉化的影響.
互聯網
Aim : To prepare and characterize the adriamycin - loaded chitosan nanoparticles of the surface - modified with glycyrrhizin ADM - CS - NPs.
目的: 制備具有肝細胞靶向的甘草酸表面修飾阿霉素殼聚糖納米粒,并考察其理化特性.
互聯網
Evaluation of myocardiotoxicity on adriamycin ( ADM ) with SPECT cardiac blood pool imaging was presented.
定期用SPECT檢測患者左心功能,評價阿霉素 ( ADM ) 對心肌的毒性作用.
互聯網
Objective : To investigate the effect of crude extract from phytolacca on adriamycin - induced nephropathy rats.
目的: 觀察商陸粗提物對大鼠阿霉素腎病模型的影響及作用.
互聯網
Copyright ? mingxiaow.com All Rights Reserved. 杭州優配網絡科技有限公司 版權所有 未經書面允許不得轉載、復制信息內容、建立鏡像
本網站內容僅供參考,請以各學校實際情況為主!內容侵權或錯誤投訴:841539661@qq.com 工信部備案號:浙ICP備20019715號